CNTX on XNAS, Health Care, Context Therapeutics Inc., job postings
Measures activity, not value. Not investment advice.
Shares fell 86% in 12 months while short interest hit 6.9M shares, 14 times a year earlier.
WatchNet loss of $43.9M over 12 months, with $34.4M cash on hand
Written by AI from the data on this page, 22 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 30 Sep 2026
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
Revenue and net income per quarter. Quarter to 30 Sep 2026: net loss $7.6M.
31 Dec 2021RevenueNet incomeNet losstallest bar $17.5M30 Sep 2026
See the numbers
Quarter to
Revenue
Net income
30 Sep 2026
–
-$7.6M
30 Jun 2026
–
-$14.6M
31 Mar 2026
–
-$8.7M
31 Dec 2025
–
-$13.0M
30 Sep 2025
–
-$9.7M
30 Jun 2025
–
-$8.8M
31 Mar 2025
–
-$4.6M
31 Dec 2024
–
-$3.3M
30 Sep 2024
–
-$17.5M
30 Jun 2024
–
-$2.3M
31 Mar 2024
–
-$3.7M
31 Dec 2023
–
-$6.8M
30 Sep 2023
–
-$5.9M
30 Jun 2023
–
-$5.0M
31 Mar 2023
–
-$6.3M
31 Dec 2022
–
-$3.6M
30 Sep 2022
–
-$3.9M
30 Jun 2022
–
-$4.0M
31 Mar 2022
–
-$3.4M
31 Dec 2021
–
-$3.1M
Fundamentals, 12 months to 30 Sep 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
–
–
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
–
+11%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
-$43.9M
-$26.4M
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
-$0.46
-$0.24
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
–
–
73.2%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
–
–
-25.0%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
–
–
-18.2%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
-84.3%
-58.8%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
–
-$22.4M
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$34.4M
$76.9M
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
$0
$0
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
-$34.4M (net cash)
-$76.9M
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
0.0
0.0
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
$0.34
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
loss
19.3
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
–
5.0
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
–
5.0
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
0.47
2.0
Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Insider Buy/Sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
–
No data for this company
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
+6.2%
85 13F filers vs 80
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
64%
58.5M shares held by 13F filers (30 Sep 2026) of 91.9M outstanding (6 Nov 2026)
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
5.1%
4.7M shares sold short (30 Oct 2026) of 91.9M outstanding (6 Nov 2026)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
3.7
4.7M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
+9.9%
4.3M shares sold short in the report before, 4.7M on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
33%
33% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 36%
Open jobs iJob postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.
–
We do not track this company's careers site yet.
Open jobs change iHow the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.
–
We do not track this company's careers site yet.
Employees iTotal staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.
–
No headcount in its annual reports in our data.
Visa hiring (foreign workers) iApplications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.
–
No data for this company
Revenue growth iSales in the latest reported quarter compared with the same quarter a year earlier.
–
No data for this company
Capital spending iMoney spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.
–
No data for this company
Federal contracts iMoney the US government committed to the company in contracts and grants over the last 12 months.
–
No data for this company
Lobbying iWhat the company reported spending on federal lobbying over the last four quarters.
–
No data for this company
Layoff notices iWorkers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).
–
No data for this company
News (7d) iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
5
5 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
5.0×
5 articles in the last 7 days; its usual week has 1.
Unusual now sharp changes in the last 90 days, compared with its own past
Short interest 6.9M, 14× a year earlier
Price $0.16 on 20 Nov 2026, -86% over 12 months (12-month range $0.16 to $3.36)
Sharp change
8-K and other filings
Insider net buying (open market). Insiders bought a net $0 in the last 12 months (the 12 months before: $107K).Capital spending per quarter. Capital spending $18K in the latest quarter.Institutional holders (13F filers). 85 13F filers reported holding it in the latest 13F quarter, +136% on a year earlier.
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, revenue per quarter, federal obligations, lobbying spend, workers in warn layoff notices.
Quarter ended 31 Mar 2021: $0; public on 12 May 2022
Quarter ended 30 Jun 2021: $0; public on 12 Aug 2022
Quarter ended 30 Sep 2021: $0; public on 10 Nov 2022
Quarter ended 31 Dec 2021: $0; public on 23 Mar 2023
Quarter ended 31 Mar 2022: $35K; public on 12 May 2022
Quarter ended 30 Jun 2022: $2K; public on 12 Aug 2022
Quarter ended 31 Mar 2023: $0, -100% on a year earlier; public on 11 May 2023
Quarter ended 30 Jun 2023: $0, -100% on a year earlier; public on 10 Aug 2023
Quarter ended 30 Sep 2023: $0; public on 10 Nov 2023
Quarter ended 31 Dec 2023: $0; public on 22 Mar 2024
Quarter ended 31 Mar 2024: $0; public on 8 May 2025
Quarter ended 30 Jun 2024: $0; public on 7 Aug 2025
Quarter ended 30 Sep 2024: $7K; public on 7 Nov 2024
Quarter ended 31 Dec 2024: $0; public on 21 Mar 2025
Quarter ended 31 Mar 2025: $34K; public on 8 May 2025
Quarter ended 30 Jun 2025: $0; public on 7 Aug 2025
Quarter ended 30 Sep 2025: $0, -100% on a year earlier; public on 6 Nov 2025
Quarter ended 31 Dec 2025: $0; public on 24 Mar 2026
Quarter ended 31 Mar 2026: $37K, +9.8% on a year earlier; public on 7 May 2026
Quarter ended 30 Jun 2026: $18K; public on 6 Aug 2026
Institutional holders (13F filers)
31 Dec 2021 report: 18; public on 14 Feb 2022
31 Mar 2022 report: 16; public on 16 May 2022
30 Jun 2022 report: 20; public on 15 Aug 2022
30 Sep 2022 report: 22; public on 14 Nov 2022
31 Dec 2022 report: 19; public on 14 Feb 2023
31 Mar 2023 report: 19; public on 15 May 2023
30 Jun 2023 report: 19; public on 14 Aug 2023
30 Sep 2023 report: 22; public on 14 Nov 2023
31 Dec 2023 report: 23; public on 14 Feb 2024
31 Mar 2024 report: 25; public on 15 May 2024
30 Jun 2024 report: 32; public on 14 Aug 2024
30 Sep 2024 report: 41; public on 14 Nov 2024
31 Dec 2024 report: 52; public on 14 Feb 2025
31 Mar 2025 report: 43; public on 15 May 2025
30 Jun 2025 report: 36; public on 14 Aug 2025
30 Sep 2025 report: 36; public on 14 Nov 2025
31 Dec 2025 report: 39; public on 17 Feb 2026
31 Mar 2026 report: 57; public on 15 May 2026
30 Jun 2026 report: 80; public on 14 Aug 2026
30 Sep 2026 report: 85; public on 16 Nov 2026
What is unusual now
Made public in the last 90 days: it had 6.9M shares sold short in the 15 Sep 2026 report, 14× the same report last year; it also had 6.5M shares sold short in the 31 Aug 2026 report, 12× the same report last year. 6 sharp changes in all.
Short interest spike: had 6.9M shares sold short in the 15 Sep 2026 report, 14× the same report last year Public on 25 Sep 2026.
Changes and notable records, by the date each became public
11 Nov 2026Short interest and volume change
had 4.7M shares sold short in the 30 Oct 2026 report, 5.5× the same report last year.
Same report last year: 848K; its normal report is 1.0M.
See the evidence
This period
4.7M (the 30 Oct 2026 report)
Normal report (median of 24 earlier)
1.0M
Typical spread (median absolute deviation)
409K
How far from its usual level
+6.1
Same report last year
848K
History used
1,827 days
the 30 Oct 2026 report24 earlier reportsnormal: 1.0M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 4.3M shares sold short in the 15 Oct 2026 report, 9.2× the same report last year.
Same report last year: 466K; its normal report is 909K.
See the evidence
This period
4.3M (the 15 Oct 2026 report)
Normal report (median of 24 earlier)
909K
Typical spread (median absolute deviation)
387K
How far from its usual level
+5.9
Same report last year
466K
History used
1,812 days
the 15 Oct 2026 report24 earlier reportsnormal: 909K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 4.7M shares sold short in the 30 Sep 2026 report, 9.5× the same report last year.
Same report last year: 493K; its normal report is 897K.
See the evidence
This period
4.7M (the 30 Sep 2026 report)
Normal report (median of 24 earlier)
897K
Typical spread (median absolute deviation)
387K
How far from its usual level
+6.6
Same report last year
493K
History used
1,797 days
the 30 Sep 2026 report24 earlier reportsnormal: 897K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 6.9M shares sold short in the 15 Sep 2026 report, 14× the same report last year.
Same report last year: 507K; its normal report is 880K.
See the evidence
This period
6.9M (the 15 Sep 2026 report)
Normal report (median of 24 earlier)
880K
Typical spread (median absolute deviation)
368K
How far from its usual level
+11.0
Same report last year
507K
History used
1,782 days
the 15 Sep 2026 report24 earlier reportsnormal: 880K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 6.5M shares sold short in the 31 Aug 2026 report, 12× the same report last year.
Same report last year: 521K; its normal report is 859K.
See the evidence
This period
6.5M (the 31 Aug 2026 report)
Normal report (median of 24 earlier)
859K
Typical spread (median absolute deviation)
341K
How far from its usual level
+11.1
Same report last year
521K
History used
1,767 days
the 31 Aug 2026 report24 earlier reportsnormal: 859K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 6.3M shares sold short in the 14 Aug 2026 report, 5.2× the same report last year.
Same report last year: 1.2M; its normal report is 859K.
See the evidence
This period
6.3M (the 14 Aug 2026 report)
Normal report (median of 24 earlier)
859K
Typical spread (median absolute deviation)
341K
How far from its usual level
+10.7
Same report last year
1.2M
History used
1,750 days
the 14 Aug 2026 report24 earlier reportsnormal: 859K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 5.8M shares sold short in the 31 Jul 2026 report, 4.8× the same report last year.
Same report last year: 1.2M; its normal report is 859K.
See the evidence
This period
5.8M (the 31 Jul 2026 report)
Normal report (median of 24 earlier)
859K
Typical spread (median absolute deviation)
341K
How far from its usual level
+9.8
Same report last year
1.2M
History used
1,736 days
the 31 Jul 2026 report24 earlier reportsnormal: 859K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.
had 1.0M shares sold short in the 31 Oct 2024 report, 20× the same report last year.
Same report last year: 50K; its normal report is 45K.
See the evidence
This period
1.0M (the 31 Oct 2024 report)
Normal report (median of 24 earlier)
45K
Typical spread (median absolute deviation)
37K
How far from its usual level
+18.0
Same report last year
50K
History used
1,098 days
the 31 Oct 2024 report24 earlier reportsnormal: 45K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 1.0M shares sold short in the 15 Oct 2024 report, 23× the same report last year.
Same report last year: 45K; its normal report is 43K.
See the evidence
This period
1.0M (the 15 Oct 2024 report)
Normal report (median of 24 earlier)
43K
Typical spread (median absolute deviation)
32K
How far from its usual level
+19.6
Same report last year
45K
History used
1,082 days
the 15 Oct 2024 report24 earlier reportsnormal: 43K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 1.1M shares sold short in the 30 Sep 2024 report, 28× the same report last year.
Same report last year: 39K; its normal report is 40K.
See the evidence
This period
1.1M (the 30 Sep 2024 report)
Normal report (median of 24 earlier)
40K
Typical spread (median absolute deviation)
26K
How far from its usual level
+21.0
Same report last year
39K
History used
1,067 days
the 30 Sep 2024 report24 earlier reportsnormal: 40K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 1.7M shares sold short in the 13 Sep 2024 report, 122× the same report last year.
Same report last year: 14K; its normal report is 38K.
See the evidence
This period
1.7M (the 13 Sep 2024 report)
Normal report (median of 24 earlier)
38K
Typical spread (median absolute deviation)
22K
How far from its usual level
+33.1
Same report last year
14K
History used
1,050 days
the 13 Sep 2024 report24 earlier reportsnormal: 38K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 1.8M shares sold short in the 30 Aug 2024 report, 252× the same report last year.
Same report last year: 7,025; its normal report is 34K.
See the evidence
This period
1.8M (the 30 Aug 2024 report)
Normal report (median of 24 earlier)
34K
Typical spread (median absolute deviation)
19K
How far from its usual level
+34.7
Same report last year
7,025
History used
1,036 days
the 30 Aug 2024 report24 earlier reportsnormal: 34K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 1.9M shares sold short in the 15 Aug 2024 report, 266× the same report last year.
Same report last year: 6,985; its normal report is 32K.
See the evidence
This period
1.9M (the 15 Aug 2024 report)
Normal report (median of 24 earlier)
32K
Typical spread (median absolute deviation)
18K
How far from its usual level
+36.5
Same report last year
6,985
History used
1,021 days
the 15 Aug 2024 report24 earlier reportsnormal: 32K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 2.0M shares sold short in the 31 Jul 2024 report, 216× the same report last year.
Same report last year: 9,363; its normal report is 29K.
See the evidence
This period
2.0M (the 31 Jul 2024 report)
Normal report (median of 24 earlier)
29K
Typical spread (median absolute deviation)
17K
How far from its usual level
+39.9
Same report last year
9,363
History used
1,006 days
the 31 Jul 2024 report24 earlier reportsnormal: 29K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 2.1M shares sold short in the 15 Jul 2024 report, 29× the same report last year.
Same report last year: 72K; its normal report is 29K.
See the evidence
This period
2.1M (the 15 Jul 2024 report)
Normal report (median of 24 earlier)
29K
Typical spread (median absolute deviation)
17K
How far from its usual level
+40.6
Same report last year
72K
History used
990 days
the 15 Jul 2024 report24 earlier reportsnormal: 29K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 2.2M shares sold short in the 28 Jun 2024 report, 15× the same report last year.
Same report last year: 150K; its normal report is 29K.
See the evidence
This period
2.2M (the 28 Jun 2024 report)
Normal report (median of 24 earlier)
29K
Typical spread (median absolute deviation)
17K
How far from its usual level
+44.0
Same report last year
150K
History used
973 days
the 28 Jun 2024 report24 earlier reportsnormal: 29K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 1.1M shares sold short in the 14 Jun 2024 report, 9.7× the same report last year.
Same report last year: 115K; its normal report is 29K.
See the evidence
This period
1.1M (the 14 Jun 2024 report)
Normal report (median of 24 earlier)
29K
Typical spread (median absolute deviation)
17K
How far from its usual level
+21.7
Same report last year
115K
History used
959 days
the 14 Jun 2024 report24 earlier reportsnormal: 29K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 1.3M shares sold short in the 31 May 2024 report, 5.2× the same report last year.
Same report last year: 253K; its normal report is 29K.
See the evidence
This period
1.3M (the 31 May 2024 report)
Normal report (median of 24 earlier)
29K
Typical spread (median absolute deviation)
17K
How far from its usual level
+25.9
Same report last year
253K
History used
945 days
the 31 May 2024 report24 earlier reportsnormal: 29K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 1.0M shares sold short in the 15 May 2024 report, 10× the same report last year.
Same report last year: 100K; its normal report is 29K.
See the evidence
This period
1.0M (the 15 May 2024 report)
Normal report (median of 24 earlier)
29K
Typical spread (median absolute deviation)
17K
How far from its usual level
+19.5
Same report last year
100K
History used
929 days
the 15 May 2024 report24 earlier reportsnormal: 29K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 606K shares sold short in the 13 Jan 2023 report, 6.1× the same report last year.
Same report last year: 100K; its normal report is 96K.
See the evidence
This period
606K (the 13 Jan 2023 report)
Normal report (median of 24 earlier)
96K
Typical spread (median absolute deviation)
40K
How far from its usual level
+8.7
Same report last year
100K
History used
441 days
the 13 Jan 2023 report24 earlier reportsnormal: 96K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Showing the newest 40 of 63 entries; narrow the window or the kind of data to see older ones.
Not listed: 58 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0001842952
Ticker
CNTX
Domain
contexttherapeutics.com
Hq location
PA|PHILADELPHIA|19103 (1 unverified)
Name
Context Therapeutics Inc.
Uei
NKF7JMWKLA31
SEC Form 13F institutional holdings180 data points31 Dec 2021 to 30 Sep 2026
SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)78 records27 May 2021 to 10 Nov 2026
SEC XBRL company facts (revenue, capex, R&D, backlog...)316 data points31 Dec 2019 to 6 Nov 2026
SEC Form 4 insider transactions19 records, 52 data points25 Oct 2021 to 10 Jun 2025
FINRA short interest (twice monthly)359 data points29 Oct 2021 to 30 Oct 2026
FINRA daily short sale volume (off-exchange)2556 data points20 Oct 2021 to 20 Nov 2026
USASpending.gov federal awards6 data points14 Sep 2016 to 10 Apr 2018